8 results
Insulin Analogs - Short, Intermediate and Long Acting - Onset, Peak, Duration

#Diabetes #Insulin #Analogs #Onset #Duration
Acting - Onset, Peak ... , Duration #Diabetes ... Onset #Duration #Peaks ... #Comparison #Pharmacology ... #Endocrinology
Insulin - Comparison - Peak and Duration

#insulin #pharmacology #duration #peak #diabetes #endocrinology #Comparison
- Comparison - Peak ... Duration #insulin #pharmacology ... #duration #peak ... #diabetes #endocrinology
The principles of insulin adjustment guidance - Schematic diagram of insulin onset and time action profiles
and Duration #Diabetes ... Analogs #Duration #Peaks ... #Comparison #Pharmacology ... #Endocrinology
The graph illustrates the differences in the onset and duration of action for various types of
Detemir, Glargine #Diabetes ... Analogs #Duration #Peaks ... Graph #Comparison #Pharmacology ... #Endocrinology
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... sarahthelyon #Diabetes ... #Medications #pharmacology ... #pathophysiology ... #endocrinology
Pathogenesis and Pathophysiology of Diabetic Ketoacidosis (DKA)

DKA is a result of an absolute or relative insulin
of Diabetic Ketoacidosis ... driven by insulin) shifts ... #Pathophysiology ... #DKA #Diabetes ... #Endocrinology
Insulin Comparison Chart

Insulin Types - Onset (hours) - Peak Glycemic Effect (hours) - Duration (hours)
 •
Onset (hours) - Peak ... Comparison #Table #pharmacology ... #diabetes #endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... • Euglycemic diabetic ... amputation and bone fractures ... #Summary #DM2 #diabetes ... #endocrinology